New domestically manufactured targeted cancer therapies, 'HERDARA' and 'IMCRANIB 100', are set to revolutionise patient access and reduce reliance on costly imports, a direct result of Her Royal Highness Princess Chulabhorn's pioneering efforts in medical innovation

Chulabhorn Royal Academy (CRA) has announced it will stop administering first doses of Covid-19 vaccine to recipients from June 14, as it had not been allocated either AstraZeneca or Sinovac jabs by the government.